DongWha Pharm to kick off trials for virus treatment
DongWha Pharm is planning to start clinical trials on its drug candidate as a potential coronavirus treatment. The Korean pharmaceutical company said last week that it is preparing a Covid-19 Phase 2 clinical trial for DW2008 next month.